ÖZge‐Anwar, 1970 - Google Patents
Slow activation of factor VIII by thrombin and other enzymes at low temperatureÖZge‐Anwar, 1970
- Document ID
- 11349341289354489105
- Author
- ÖZge‐Anwar A
- Publication year
- Publication venue
- Scandinavian Journal of Haematology
External Links
Snippet
The activation of factor VIII by thrombin and reptilase in human fraction I‐O is described. The evidence is presented showing the presence of factor VIII activity in the supernatant fluid of the thrombin treated fraction I‐O in the process of clot formation. Factor VIII activity is more …
- 108010054218 Factor VIII 0 title abstract description 39
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Marder et al. | High molecular weight derivatives of human fibrinogen produced by plasmin: II. Mechanism of their anticoagulant activity | |
Colman et al. | Studies on the prekallikrein (kallikreinogen)-kallikrein enzyme system of human plasma: I. Isolation and purification of plasma kallikreins | |
Christensen et al. | A proteolytic enzyme of serum: characterization, activation, and reaction with inhibitors | |
Liotta et al. | Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin | |
Ariëns et al. | Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms | |
Suzuki et al. | Thrombin-catalyzed activation of human coagulation factor V. | |
Cochrane et al. | Activation of Hageman factor in solid and fluid phases: a critical role of kallikrein | |
Andrade-Gordon et al. | Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen | |
Deutsch et al. | Differentiation of certain platelet factors related to blood coagulation | |
Reber et al. | Three abnormal fibrinogen variants with the same amino acid substitution (γ 275 Arg→ His): Fibrinogens Bergamo II, Essen and Perugia | |
JP2008289498A (en) | Purified multimerase | |
Saito et al. | Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin | |
Oesterud et al. | Activation of the coagulation factor VII by tissue thromboplastin and calcium | |
Haverkate et al. | Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis | |
Furlan et al. | Effect of calcium and synthetic peptides on fibrin polymerization | |
Suzuki et al. | Normal titer of functional and immunoreactive protein-C inhibitor in plasma of patients with congenital combined deficiency of factor V and factor VIII | |
Bithell | Hereditary dysfibrinogenemia. | |
Bonilla | Defibrinating enzyme from timber rattlesnake (Crotalus H. Horridus) venom: A potential agent for therapeutic defibrination I. Purification and properties | |
ÖZge‐Anwar | Slow activation of factor VIII by thrombin and other enzymes at low temperature | |
Abildgaard | Heparin cofactor and antithrombin | |
Miller-Andersson et al. | Preparation and stability of a highly purified human thrombin standard | |
Henriksson et al. | Granulocyte elastase activation and degradation of factor XIII | |
Blombäck et al. | Action of a proteolytic enzyme inhibitor on blood coagulation in vitro | |
Dyr et al. | The fibrinogenolytic and procoagulant activity of southern copperhead venom enzymes | |
Bode et al. | Generation and degradation of fibrinopeptide A in stored platelet concentrate |